It is currently unclear whether prophylactic surgery for children with asymptomatic TCS can prevent the development of future neurological deficits. Regarding the natural course of asymptomatic TCS, conversion to symptomatic TCS is reported at a rate of 3%–4% per year [
3-
5]; hence, it seems natural to consider preventive surgery. However, several studies investigating the success of early preventive surgery have reported conflicting outcomes. Kulkarni et al. [
3] performed conservative therapy in 53 patients with lipomas of the spinal cord conus. During the 9-year follow-up period, there was no significant difference in the appearance of neurological symptoms between the conservatively treated and early surgery groups. However, the expression rate of delayed neurological deficits was lower in the conservative therapy group (33% in the conservative therapy group versus 46% in the early surgery group). Wykes et al. [
5] performed conservative treatment for 56 patients with asymptomatic lipomas of the spinal cord conus with 71% of patients being asymptomatic during the mean follow-up period of 5.9 years. Furthermore, the hazard ratio of becoming symptomatic was 40% in 10 years. Both groups had a negative opinion of prophylactic surgery for asymptomatic TCS. Regarding delayed neurological deficits after prophylactic surgery for asymptomatic TCS, Arai et al. [
6] reported that three (8.3%) out of 36 cases exhibited delayed neuropathy 3–6 years after surgery. In these patients, no lesions, such as a re-tethered cord or syringomyelia, were detected on MRI. Hence, the authors considered dysplasia of the lower spinal cord to be involved with the onset of symptoms. In contrast, La Marca et al. [
7] reported that 28 patients with asymptomatic filum terminale lipoma who underwent prophylactic surgery exhibited no delayed neurological deficits (mean follow-up period, 3.4 years). However, of 71 patients, nine (12.7%) with asymptomatic spinal cord conus lipomas exhibited delayed neurological deficits after prophylactic surgery. Talamonti et al. [
4] performed prophylactic surgery (mean follow-up period, 9.7 years) or conservative therapy (mean follow-up period, 10.4 years) for 56 patients with asymptomatic spinal conus lipomas. During the follow-up period, delayed neurological deficits were observed in 9.7% of patients who underwent prophylactic surgery and in 29.1% of those who underwent conservative therapy. Although there was no statistically significant difference between both groups, the results suggested that prophylactic surgery is useful for asymptomatic spinal cord conus lipomas (
p=0.067). In our study, the results of prophylactic surgery for 14 children with asymptomatic TCS revealed that all children remained asymptomatic until 94 months after the initial surgery. However, two children (14.3%) exhibited delayed motor and sensory disturbances or bowel and bladder dysfunctions due to a re-tethered cord. Of these children, one underwent reuntethering surgery.
Although the small patient population is a limitation of our study, the results seem acceptable given the annual incidence of delayed neurological deficits is 3.7%–4.0% as reported by Kulkarni et al. [
3] and Wykes et al. [
5] (annual deterioration rate in our study, 1.8%). Kanev and Bierbrauer [
8] retrospectively analyzed children with lipomeningocele and showed that the incidence of neurological symptoms increased with increasing age. Regarding the surgical timing for asymptomatic TCS, Seki et al. [
9] reviewed 31 pediatric patients with TCS and reported that patients with asymptomatic TCS underwent surgery significantly earlier than patients with symptomatic TCS (
p=0.045). In addition, Hoffman et al. [
10] examined 97 patients with lipomyelomeningocele and found that 62.5% of patients aged >6 months who underwent prophylactic surgery remained asymptomatic, whereas 70.7% of those aged >6 months who underwent prophylactic surgery became symptomatic. Taken together, these reports suggested that the age of the patient during prophylactic surgery for TCS is a risk factor for the onset of neurological symptoms. Furthermore, the age of the patient should be carefully considered during prophylactic surgery for asymptomatic TCS.